These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3045034)

  • 1. Deregulation of hypothalamic opioid and luteinizing hormone releasing factor (LHRF) activity and its relevance to Tourette's syndrome.
    Sandyk R; Bamford CR
    Int J Neurosci; 1988 Apr; 39(3-4):223-4. PubMed ID: 3045034
    [No Abstract]   [Full Text] [Related]  

  • 2. The hypothalamic luteinizing hormone releasing hormone "pulse generator" and the opioid system in Tourette's syndrome.
    Sandyk R; Bamford CR
    Int J Neurosci; 1988 Jul; 41(1-2):81-2. PubMed ID: 3137184
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of prolactin release by luteinizing hormone-releasing hormone in Tourette's syndrome.
    Sandyk R; Bamford CR
    Int J Neurosci; 1988 Jun; 40(3-4):217-8. PubMed ID: 3042658
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid-serotoninergic dysregulation in the pathophysiology of Tourette's syndrome.
    Sandyk R; Bamford CR
    Funct Neurol; 1988; 3(2):225-35. PubMed ID: 3042531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin deficiency in Tourette's syndrome.
    Sandyk R
    Int J Neurosci; 1989 May; 46(1-2):65-6. PubMed ID: 2570046
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor.
    Nikolarakis KE; Almeida OF; Sirinathsinghji DJ; Herz A
    Neuroendocrinology; 1988 Jun; 47(6):545-50. PubMed ID: 2840600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among concentrations of four opioid neuropeptides and luteinizing hormone-releasing hormone in neural tissues of beef cows following early weaning.
    Malven PV; Parfet JR; Gregg DW; Allrich RD; Moss GE
    J Anim Sci; 1986 Mar; 62(3):723-33. PubMed ID: 2871005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro perifusion of human hypothalamic and pituitary tissue.
    Rasmussen DD
    Methods Enzymol; 1989; 168():206-18. PubMed ID: 2657332
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal opiate receptor functions in Tourette's syndrome.
    Sandyk R
    Int J Neurosci; 1989 Feb; 44(3-4):209-14. PubMed ID: 2542175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of hypothalamic dopamine and opioid activity and the pathophysiology of self-mutilatory behavior in Tourette's syndrome.
    Sandyk R; Bamford CR
    J Clin Psychopharmacol; 1987 Oct; 7(5):367. PubMed ID: 3479458
    [No Abstract]   [Full Text] [Related]  

  • 11. Sleep disorders in Tourette's syndrome.
    Sandyk R; Bamford CR; Iacono RP
    Int J Neurosci; 1987 Nov; 37(1-2):59-65. PubMed ID: 3479403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual hormones in the pathophysiology of Tourette's syndrome.
    Sandyk R; Bamford CR; Iacono RP
    Int J Neurosci; 1988 Jan; 38(1-2):125-9. PubMed ID: 3162726
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of the hypothalamic pulse generator: insufficient or inappropriate gonadotropin-releasing hormone release.
    Casper RF
    Clin Obstet Gynecol; 1990 Sep; 33(3):611-21. PubMed ID: 2171823
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid modulation of gonadotrophin release in Tourette's syndrome.
    Sandyk R; Bamford CR
    Int J Neurosci; 1988 Apr; 39(3-4):233-4. PubMed ID: 3137181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin deficiency in Tourette's syndrome: a preliminary communication.
    Sandyk R; Bamford CR; Binkiewicz A; Finley PR
    Int J Neurosci; 1988 Sep; 42(1-2):121-5. PubMed ID: 3145253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of testosterone in regulating hypothalamic content and in vitro release of beta-endorphin and dynorphin.
    Almeida OF; Nikolarakis KE; Herz A
    J Neurochem; 1987 Sep; 49(3):742-7. PubMed ID: 2886553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic inactivation of luliberin (luteinizing-hormone-releasing hormone) [proceedings].
    Kelly JA; Griffiths EC; Jeffcoate SL; Hopkinson CR
    Biochem Soc Trans; 1979 Feb; 7(1):76-7. PubMed ID: 374154
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative distribution of somatostatin, LH-RH, neurophysin, and alpha-endorphin in the rainbow trout: an immunocytological study.
    Dubois MP; Billard R; Breton B; Peter RE
    Gen Comp Endocrinol; 1979 Feb; 37(2):220-32. PubMed ID: 376398
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in photoperiod alter the daily rhythms of pineal melatonin content and hypothalamic beta-endorphin content and the luteinizing hormone response to naloxone in the male Syrian hamster.
    Roberts AC; Martensz ND; Hastings MH; Herbert J
    Endocrinology; 1985 Jul; 117(1):141-8. PubMed ID: 3159563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of the gonadotrophin releasing hormone pulse generator in relation to opioid and nutritional cues.
    Jenkins PJ; Grossman A
    Hum Reprod; 1993 Nov; 8 Suppl 2():154-61. PubMed ID: 8276951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.